期刊文献+

陕西省脊髓灰质炎病毒检测分析 被引量:2

Detection of acute flaccid paralysis (AFP) cases and poliovirus in Shaanxi province
原文传递
导出
摘要 目的分析陕西省2003-2008年检出脊髓灰质炎(以下简称脊灰)病毒(PV)的急性弛缓性麻痹(AFP)病例流行病学特征,提高对疫苗衍生脊灰病毒(VDPV)监测的敏感性。方法对PV阳性的AFP病例相关资料进行流行病学分析,对疫苗变异PV采用VP1基因核苷酸序列测定方法进行分子生物学性状分析。结果陕西省2003-2008年共检出PV 29株,分离到的PV以Ⅱ型为主(15株),超过Ⅰ型和Ⅲ型之和;AFP病例集中在≤2岁儿童(75.86%),以零剂次免疫和未全程免疫儿童所占比例较大(51.72%);麻痹部位主要为单下肢、双下肢和四肢;型内鉴定14株为疫苗变异PV,基因序列测定均未达到VDPV(1%)的诊断标准;疫苗变异PV的病例中7例为未全程免疫,9例为0~2岁儿童。结论维持无脊灰阶段,存在着VDPV和发生循环疫苗衍生脊灰病毒(cVDPVs)爆发流行的可能,保持高水平的脊灰减毒活疫苗(OPV)免疫覆盖率,高质量的AFP病例流行病学监测和病毒学监测,具有重要现实意义。 Objective To analyze the epidemiological character of AFP cases and to detect poliovirus in Shaanxi province during 2003-2008 in order to increase the sensitivity of vaccine-derived poliovirus(VDPVs) surveillance.Methods Epidemiological analysis was conducted in AFP cases with positive poliovirus detection and VP1 genomic sequencing technique was used to analyze the molecular character of vaccine-variant polioviruses.Results From 2003 to 2008,29 poliovirus strains were isolated from AFP cases,and the number of type Ⅱ strains exceed to the summation of type Ⅰ and type Ⅲ strains.75.86% of cases were children.The main paralysis parts of body were single or both lower extremity and limbs.Fourteen strains were indentified as vaccine-variant poliovirus.The variant rate of VP1 sequence did not reach 1%.Among these cases,7 cases were not fully vaccinated children and 9 were under 2 years old.Conclusion VDPV emergence and cVDPVs circulation still possibly occur in course of polio-eradication.It is important to keep high-level surveillance and vaccination coverage.
出处 《中国公共卫生》 CAS CSCD 北大核心 2010年第9期1126-1127,共2页 Chinese Journal of Public Health
基金 陕西省卫生厅科研基金(04C08)
关键词 脊髓灰质炎病毒 疫苗衍生脊髓灰质炎病毒 监测 流行病学 poliovirus(PV) vaccine-derived poliovirus(VDPV) surveillence epidemiology
  • 相关文献

参考文献5

二级参考文献25

  • 1[1]Horaud F,Albert B.Sabin and the development of oral polio vaccine[J].Biological,1993,21:311-316.
  • 2[2]Kew O M,Nottay B K,Hatch M H,et al.Multiple genetic changes can occur in the oral polio vaccines upon replication in humans[J].J Gen Virol,1998,156:337-347.
  • 3[3]Balanat J,Guillot S,Candrea A,et al.The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay[J].Virology,1991,184:645-654.
  • 4[4]Bouchard M J,Lam D H,Racaniello V R,et al.Determinants of Attenuation and Temperature Sensitivity in the Type Ⅰ Poliovirus Sabin Vaccine[J].J Virology,1995,69(8):4972-4978.
  • 5[5]Ren R B,Moss E G,Racaniello V R,et al.Identification of Two Determinants that Attenuate Vaccine-Related Type Ⅱ Poliovirus[J].J Virology,1991,65(3):1377-1382.
  • 6[6]Almond J W,Westrop G D,Evans D M A,et al.Studies on the Attenuation of the Sabin Type Ⅲ Oral Polio Vaccine[J].J Virol Meth,1987,17:183-189.
  • 7[7]Joce R,Wood D,Brown D,et al.Paralytic Poliomyelitis in England and Wales,1985-91[J].Br Med J,1992,305:79-82.
  • 8[8]Almond J W.The Attenuation of Poliovirus Neurovirulence[J].Microbiol,1987,41:153-180.
  • 9[9]Minor P D,Macadam A J,Stone D M,et al.Genetic Basis of Attenuation of the Sabin Oral Poliovirus Vaccines[J].Biological,1993,21:357-363.
  • 10[10]Friedrich F.Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans[J].Acta Virologica,1998,42:187-195.

共引文献56

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部